Expert Interview
Digging into the phase 2 KRYSTAL-7 clinical trial results of adagrasib with pembrolizumab as a treatment for non-small cell lung cancer as presented at ESMO 2023
Ticker(s): MRTX, MRKInstitution: Mount Sinai
- Assistant professor of Medicine, Hematology and Medical Oncology, and a board certified medical oncologist who specializes in the treatment of lung cancer and other thoracic malignancies.
- Translational researcher focused on studying predictive biomarkers and developing novel targeted and immunotherapy trials aimed at improving treatment outcomes in lung cancer patients.
- PI of several lung cancer trials, including investigator initiated trials based on proteogenomic analyses used to identify novel therapeutic targets.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
